164 related articles for article (PubMed ID: 37658588)
1. METTL3-stabilized super enhancers-lncRNA SUCLG2-AS1 mediates the formation of a long-range chromatin loop between enhancers and promoters of SOX2 in metastasis and radiosensitivity of nasopharyngeal carcinoma.
Hu X; Wu J; Feng Y; Ma H; Zhang E; Zhang C; Sun Q; Wang T; Ge Y; Zong D; Chen W; He X
Clin Transl Med; 2023 Sep; 13(9):e1361. PubMed ID: 37658588
[TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNA PTPRG-AS1/microRNA-124-3p regulates radiosensitivity of nasopharyngeal carcinoma via the LIM Homeobox 2-dependent Notch pathway through competitive endogenous RNA mechanism.
Shen Z; Wu Y; He G
Bioengineered; 2022 Apr; 13(4):8208-8225. PubMed ID: 35300558
[TBL] [Abstract][Full Text] [Related]
3. Super-enhancer driven SOX2 promotes tumor formation by chromatin re-organization in nasopharyngeal carcinoma.
Liu SX; Wang C; Lin RB; Ding WY; Roy G; Wang HB; Yang T; Liu Q; Luo YL; Jin SL; Zeng MS; Zhao B; Zhong Q
EBioMedicine; 2023 Dec; 98():104870. PubMed ID: 37967508
[TBL] [Abstract][Full Text] [Related]
4. Regulatory function and mechanism research for m6A modification WTAP via SUCLG2-AS1- miR-17-5p-JAK1 axis in AML.
Liu M; Yu B; Tian Y; Li F
BMC Cancer; 2024 Jan; 24(1):98. PubMed ID: 38233760
[TBL] [Abstract][Full Text] [Related]
5. Long noncoding RNA PTPRG-AS1 acts as a microRNA-194-3p sponge to regulate radiosensitivity and metastasis of nasopharyngeal carcinoma cells via PRC1.
Yi L; Ouyang L; Wang S; Li SS; Yang XM
J Cell Physiol; 2019 Aug; 234(10):19088-19102. PubMed ID: 30993702
[TBL] [Abstract][Full Text] [Related]
6. Up-regulated long non-coding RNA ILF3-AS1 indicates poor prognosis of nasopharyngeal carcinoma and promoted cell metastasis.
Yang X; Lin F; Gao F
Int J Biol Markers; 2020 Dec; 35(4):61-70. PubMed ID: 32962500
[TBL] [Abstract][Full Text] [Related]
7. Long noncoding RNA AFAP1-AS1 acts as a competing endogenous RNA of miR-423-5p to facilitate nasopharyngeal carcinoma metastasis through regulating the Rho/Rac pathway.
Lian Y; Xiong F; Yang L; Bo H; Gong Z; Wang Y; Wei F; Tang Y; Li X; Liao Q; Wang H; Zhou M; Xiang B; Wu X; Li Y; Li X; Chen X; Li G; Guo C; Zeng Z; Xiong W
J Exp Clin Cancer Res; 2018 Oct; 37(1):253. PubMed ID: 30326930
[TBL] [Abstract][Full Text] [Related]
8. LncRNA DSCAM-AS1 interacts with YBX1 to promote cancer progression by forming a positive feedback loop that activates FOXA1 transcription network.
Zhang Y; Huang YX; Wang DL; Yang B; Yan HY; Lin LH; Li Y; Chen J; Xie LM; Huang YS; Liao JY; Hu KS; He JH; Saw PE; Xu X; Yin D
Theranostics; 2020; 10(23):10823-10837. PubMed ID: 32929382
[No Abstract] [Full Text] [Related]
9. Long noncoding RNA PXN-AS1-L promotes the malignancy of nasopharyngeal carcinoma cells via upregulation of SAPCD2.
Jia X; Niu P; Xie C; Liu H
Cancer Med; 2019 Aug; 8(9):4278-4291. PubMed ID: 31173488
[TBL] [Abstract][Full Text] [Related]
10. LncRNA FOXD3-AS1 Promotes the Malignant Progression of Nasopharyngeal Carcinoma Through Enhancing the Transcription of YBX1 by H3K27Ac Modification.
Yang H; Pan Y; Zhang J; Jin L; Zhang X
Front Oncol; 2021; 11():715635. PubMed ID: 34395290
[TBL] [Abstract][Full Text] [Related]
11. JUN-induced super-enhancer RNA forms R-loop to promote nasopharyngeal carcinoma metastasis.
Jia Q; Tan Y; Li Y; Wu Y; Wang J; Tang F
Cell Death Dis; 2023 Jul; 14(7):459. PubMed ID: 37479693
[TBL] [Abstract][Full Text] [Related]
12. LncRNA TP73-AS1 regulates miR-495 expression to promote migration and invasion of nasopharyngeal carcinoma cells through junctional adhesion molecule A.
Dai BQ; Jiang X; Feng LC
Kaohsiung J Med Sci; 2021 May; 37(5):361-370. PubMed ID: 33400379
[TBL] [Abstract][Full Text] [Related]
13. m6A-enriched lncRNA LINC00839 promotes tumor progression by enhancing TAF15-mediated transcription of amine oxidase AOC1 in nasopharyngeal carcinoma.
Zheng WH; Long ZQ; Zheng ZQ; Zhang LL; Liang YL; Li ZX; Lv JW; Kou J; Hong XH; He SW; Xu R; Zhou GQ; Liu N; Ma J; Sun Y; Lin L; Wei D
J Biol Chem; 2023 Jul; 299(7):104873. PubMed ID: 37257820
[TBL] [Abstract][Full Text] [Related]
14. METTL3 facilitates tumor progression via an m
Li T; Hu PS; Zuo Z; Lin JF; Li X; Wu QN; Chen ZH; Zeng ZL; Wang F; Zheng J; Chen D; Li B; Kang TB; Xie D; Lin D; Ju HQ; Xu RH
Mol Cancer; 2019 Jun; 18(1):112. PubMed ID: 31230592
[TBL] [Abstract][Full Text] [Related]
15. LncRNA BBOX1-AS1 Contributes to the Development of Nasopharyngeal Carcinoma via miR-204-5p/MUC4 Axis.
Xiong J; Zhou L; Zhou Y
Ann Clin Lab Sci; 2023 May; 53(3):366-379. PubMed ID: 37437933
[TBL] [Abstract][Full Text] [Related]
16. Upregulated long non-coding RNA AFAP1-AS1 expression is associated with progression and poor prognosis of nasopharyngeal carcinoma.
Bo H; Gong Z; Zhang W; Li X; Zeng Y; Liao Q; Chen P; Shi L; Lian Y; Jing Y; Tang K; Li Z; Zhou Y; Zhou M; Xiang B; Li X; Yang J; Xiong W; Li G; Zeng Z
Oncotarget; 2015 Aug; 6(24):20404-18. PubMed ID: 26246469
[TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA GNAS-AS1 promotes cell migration and invasion via regulating Wnt/β-catenin pathway in nasopharyngeal carcinoma.
Wang XQ; Xu H; Wang CH; Xie H
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):3077-3084. PubMed ID: 32271425
[TBL] [Abstract][Full Text] [Related]
18. Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma.
Yuan J; Jiang YY; Mayakonda A; Huang M; Ding LW; Lin H; Yu F; Lu Y; Loh TKS; Chow M; Savage S; Tyner JW; Lin DC; Koeffler HP
Cancer Res; 2017 Dec; 77(23):6614-6626. PubMed ID: 28951465
[TBL] [Abstract][Full Text] [Related]
19. LncRNA SATB2-AS1 inhibits tumor metastasis and affects the tumor immune cell microenvironment in colorectal cancer by regulating SATB2.
Xu M; Xu X; Pan B; Chen X; Lin K; Zeng K; Liu X; Xu T; Sun L; Qin J; He B; Pan Y; Sun H; Wang S
Mol Cancer; 2019 Sep; 18(1):135. PubMed ID: 31492160
[TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA FOXP4-AS1 acts as an adverse prognostic factor and regulates proliferation and apoptosis in nasopharyngeal carcinoma.
Zhong LK; Zhou J; He X; He BF; Zhou XW; Zhu JL; Liu J; Qiu YH
Eur Rev Med Pharmacol Sci; 2020 Aug; 24(15):8008-8016. PubMed ID: 32767327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
